Impact of Underlying Renal Disease and Immunosuppressive Regimen on Ovarian Reserve in Renal Patients
Impact of Underlying Renal Disease and Immunosuppressive Regimen on Ovarian Reserve in Renal Patients
Aging, renal pathology (eg SLE, ADPKD), X-ray exposition and pharmacological treatments,
 especially previous strong immunosuppression, may negatively influence the ovarian reserve in
 childbearing age women. Anti-Müllerian hormone (AMH) is regarded as biomarker for ovarian
 reserve.

 Every female with renal disease regularly menstruating that met exclusion criteria could have
 participated. The aim was to assess ovarian reserve in female patients with normal menstrual
 cycle and kidney disease, including kidney transplant recipients.
Inclusion Criteria:

 -  Conscious written approval

 -  Autoimmunological disorder with kidneys affection/ kidney transplant recipient-
 Regular menstrual cycles

 -  Age above 18 years old

 Exclusion Criteria:

 -  Irregular menstrual cycles

 -  Menopause

 -  PCOS

 -  Chemiotherapy or radiotherapy in the past

 -  Surgical interventions within ovaries

 -  Hypogonadotropic hypogonadism

 -  Folliculoma

 -  Age under 18 years old